<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Department of Ophthalmology News and Stories

rare disease

Research    Uveitis & Ocular Immunology    rare disease

Why Defining Ocular Sarcoidosis Could Be Helpful to Doctors and Patients

Doctors often describe sarcoidosis as a diagnosis of exclusion.

Author Kara Mason | Publish Date February 15, 2024
Full Story

Patient Care    Drug Development    Retina    rare disease

CU Ophthalmologists Administer Novel Treatment for Single Patient Facing Rare Genetic Condition

Thirteen-year-old Grace Hoyt received potentially the best birthday gift ever this month when pediatric ophthalmologists at the University of Colorado School of Medicine and Children’s Hospital Colorado administered the first treatment designed specifically to slow her vision loss associated with posterior column ataxia with retinitis pigmentosa (PCARP), a rare genetic condition that affects vision and the nervous system.

Author Kara Mason | Publish Date September 06, 2023
Full Story

See Us In the News


NuFund Venture Group Highlights Eyegenex’s Innovative Breakthroughs in Ophthalmic Care

news outletCityBiz
Publish DateJuly 16, 2024

Ram Nagaraj, PhD, professor of ophthalmology at the University of Colorado School of Medicine and chief scientific advisor for EyeGenex, has obtained new patents in the pursuit of pioneering drugs for glaucoma and diabetic retinopathy to prevent blindness. 

Full Story
Drug Discovery News

Mini-retinas model human disease in a dish

news outletDrug Discovery News
Publish DateJuly 16, 2024

Researchers from the Department of Ophthalmology at the University of Colorado School of Medicine describe how they use retinal organoids to screen drugs and hope to transplant them into the eyes of people with blindness in the coming years.

Full Story

First patient at UCHealth receives new treatment for Alzheimer’s disease

news outletUCHealth
Publish DateJuly 03, 2024

Leqembi is not a cure for Alzheimer’s. But it’s the first FDA-approved drug that has shown evidence of slowing cognitive declines. UCHealth medical experts have now set up a safe system to screen patients and give infusions of Leqembi to those who qualify.

Full Story
Clinical Insights in Eyecare

Case Report: Neurotrophic Ulcer Secondary to a Hypoplastic Trigeminal Nerve in a Three-Year-Old Boy

news outletClinical Insights in Eyecare
Publish DateJuly 03, 2024

Kaleb Abbott, OD, MS, FAAO, Melissa Engle, OD, FAAO, and Emily McCourt, MD, present a challenging case of a boy aged 3 years with a refractory neurotrophic ulcer secondary to congenital trigeminal anesthesia treated with recombinant human nerve growth factor and corneal neurotization surgery.

Full Story